Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
Titel:
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
Auteur:
Eide, Christopher A. Brewer, Diana Xie, Tao Schultz, Anna Reister Savage, Samantha L. Muratcioglu, Serena Merz, Noah Press, Richard D. O’Hare, Thomas Jacob, Thomas Vu, Tania Q. Tognon, Cristina E. Macey, Tara A. Kuriyan, John Kalodimos, Charalampos G. Druker, Brian J.